We are a clinical-stage biotechnology company developing cellular therapies for aging-related and life-threatening conditions. Our lead investigational product is Lomecel-B, which is derived from culture-expanded medicinal signaling cells (MSCs) that are sourced from bone marrow of young healthy
Location: United States, Florida, Miami
Employees: 11-50
Total raised: $6.7M
Founded date: 2014
Investors 1
| Date | Name | Website |
| - | TEDCO | tedcomd.co... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.11.2018 | Grant | $6.7M | TEDCO |
Mentions in press and media 6
| Date | Title | Description | Source |
| 18.04.2024 | Longeveron Raises a Total of $11.4 Million in Gross Proceeds... | - | globenewsw... |
| 21.09.2021 | Longeveron : Announces Dr. Jorge Ruiz as Speaker for Roundta... | -- Jorge Ruiz, M.D., Associate Director for Clinical Affairs, Geriatric Research at the Miami VA Hea... | marketscre... |
| 13.08.2021 | Longeveron : Announces Topline Results of Phase 2b Study of ... | -- Study meets one of the two analyses of primary efficacy endpoint: statistically significant dose-... | marketscre... |
| 11.02.2021 | Longeveron Inc. Announces Pricing of an Upsized $26.6 Millio... | MIAMI, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or &q... | globenewsw... |
| 06.11.2018 | Longeveron Wins $6.7 Million in Grant Funding, Including a $... | Longeveron LLC is a regenerative medicine company developing cellular solutions for aging-related di... | archive.ci... |
| 06.11.2018 | Longeveron Wins $6.7 Million in Grant Funding, Including a $... | Longeveron LLC is a regenerative medicine company developing cellular solutions for aging-related di... | citybizlis... |